Skip to main content
Top
Published in: Critical Care 1/2019

Open Access 01-12-2019 | Vancomycin | Letter

Attainment of therapeutic vancomycin level within the first 24 h

Authors: Patrick M. Honore, David De Bels, Rachid Attou, Sebastien Redant, Andrea Gallerani, Kianoush Kashani

Published in: Critical Care | Issue 1/2019

Login to get access

Excerpt

Attaining adequate vancomycin levels among critically ill patients is an important issue. The early achievement of this target potentially avoids therapy failure, the emergence of multiresistant bacterial strains, and even possibly increased mortality [1, 2]. The primary goal of the study by Batista and colleagues [1], who used a creatinine clearance (ClCr)-based nomogram, was reaching the vancomycin target level with continuous infusion (CI) strategy. The authors reported no additional risk of nephrotoxicity and found CI to be superior to a loading dose of 35 mg/kg [1, 3]. Augmented renal clearance (ARC; creatinine clearance > 130 ml/min) was present in 40% of critically ill patients without acute kidney injury. The target vancomycin level of 20–30 mg/L at 24 h was achieved in 84% of patients [1]. Cristillini et al., in a cohort with a 21% incidence of ARC, used a loading dose of 35 mg/kg in 4 h and achieved the same target vancomycin (at 24 h) trough levels in 54% of the patients [4]. Vancomycin dosing during continuous renal replacement therapy (CRRT) is challenging and yet very important. Beumier et al. described that a 35-mg/kg loading dose during CRRT allows therapeutic vancomycin target level attainment in 63% of patients within 24 h [5]. Unfortunately, dosing nomogram proposed by Batista et al. has not been assessed in patients treated with RRT [1]. At this point, considering the lack of data, the loading vancomycin dose of 35 mg/kg remains the gold standard in CRRT patients. As there is a critical need to ascertain the most effective strategy to attain vancomycin therapeutic trough levels in patients treated with CRRT, future studies need to compare Batista et al. dosing protocol with the current standard of care. …
Literature
1.
go back to reference Baptista JP, Roberts JA, Sousa E, Freitas R, Deveza N, Pimente LJ. decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram. Crit Care. 2014;18:654.CrossRef Baptista JP, Roberts JA, Sousa E, Freitas R, Deveza N, Pimente LJ. decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram. Crit Care. 2014;18:654.CrossRef
2.
go back to reference Claus BO, Hoste EA, Colpaert K, Robays H, Decruyenaere J, De Waele JJ. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013;28:695–700.CrossRef Claus BO, Hoste EA, Colpaert K, Robays H, Decruyenaere J, De Waele JJ. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013;28:695–700.CrossRef
3.
go back to reference Roberts JATF, Udy AA, Vincent JL, Jacobs F, Lipman J. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother. 2011;55:2704–9.CrossRef Roberts JATF, Udy AA, Vincent JL, Jacobs F, Lipman J. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother. 2011;55:2704–9.CrossRef
5.
go back to reference Beumier M, Roberts JA, Kabtouri H, Hites M, Cotton F, Wolff F, et al. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy. J Antimicrob Chemother. 2013;68:2859–65.CrossRef Beumier M, Roberts JA, Kabtouri H, Hites M, Cotton F, Wolff F, et al. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy. J Antimicrob Chemother. 2013;68:2859–65.CrossRef
Metadata
Title
Attainment of therapeutic vancomycin level within the first 24 h
Authors
Patrick M. Honore
David De Bels
Rachid Attou
Sebastien Redant
Andrea Gallerani
Kianoush Kashani
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Vancomycin
Published in
Critical Care / Issue 1/2019
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-019-2515-5

Other articles of this Issue 1/2019

Critical Care 1/2019 Go to the issue